Platten M - Search Results

1

Large-scale characterization of the microvascular geometry in development and disease by tissue clearing and quantitative ultramicroscopy.

Hahn A, Bode J, Alexander A, Karimian-Jazi K, Schregel K, Schwarz D, Sommerkamp AC, Krüwel T, Abdollahi A, Wick W, Platten M, Bendszus M, Tews B, Kurz FT, Breckwoldt MO. Hahn A, et al. Among authors: platten m. J Cereb Blood Flow Metab. 2021 Jul;41(7):1536-1546. doi: 10.1177/0271678X20961854. Epub 2020 Oct 12. J Cereb Blood Flow Metab. 2021. PMID: 33043767 Free PMC article.

2

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Platten M, Wick W, Weller M. Platten M, et al. Microsc Res Tech. 2001 Feb 15;52(4):401-10. doi: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C. Microsc Res Tech. 2001. PMID: 11170299 Review.

3

Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.

Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, Weller M. Wick W, et al. Among authors: platten m. J Neurosci. 2001 May 15;21(10):3360-8. doi: 10.1523/JNEUROSCI.21-10-03360.2001. J Neurosci. 2001. PMID: 11331365 Free PMC article.

4

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.

Platten M, Wild-Bode C, Wick W, Leitlein J, Dichgans J, Weller M. Platten M, et al. Int J Cancer. 2001 Jul 1;93(1):53-61. doi: 10.1002/ijc.1289. Int J Cancer. 2001. PMID: 11391621 Free article.

5

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-gamma (IFN-gamma).

Platten M, Wick W, Wischhusen J, Weller M. Platten M, et al. Br J Pharmacol. 2001 Nov;134(6):1279-84. doi: 10.1038/sj.bjp.0704373. Br J Pharmacol. 2001. PMID: 11704648 Free PMC article.

6

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

Wick W, Platten M, Weller M. Wick W, et al. Among authors: platten m. J Neurooncol. 2001 Jun;53(2):177-85. doi: 10.1023/a:1012209518843. J Neurooncol. 2001. PMID: 11716069 Review.

7

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.

Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M. Uhl M, et al. Among authors: platten m. Cancer Res. 2004 Nov 1;64(21):7954-61. doi: 10.1158/0008-5472.CAN-04-1013. Cancer Res. 2004. PMID: 15520202

8

Tryptophan degradation in autoimmune diseases.

Opitz CA, Wick W, Steinman L, Platten M. Opitz CA, et al. Among authors: platten m. Cell Mol Life Sci. 2007 Oct;64(19-20):2542-63. doi: 10.1007/s00018-007-7140-9. Cell Mol Life Sci. 2007. PMID: 17611712 Review.

9

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.

Wick A, Felsberg J, Steinbach JP, Herrlinger U, Platten M, Blaschke B, Meyermann R, Reifenberger G, Weller M, Wick W. Wick A, et al. Among authors: platten m. J Clin Oncol. 2007 Aug 1;25(22):3357-61. doi: 10.1200/JCO.2007.10.7722. J Clin Oncol. 2007. PMID: 17664483 Clinical Trial.

10

New (alternative) temozolomide regimens for the treatment of glioma.

Wick W, Platten M, Weller M. Wick W, et al. Among authors: platten m. Neuro Oncol. 2009 Feb;11(1):69-79. doi: 10.1215/15228517-2008-078. Epub 2008 Sep 4. Neuro Oncol. 2009. PMID: 18772354 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page